The Effects of a Community-Based Sodium Reduction Program in Rural China – A Cluster-Randomized Trial
Nicole Li(George Institute for Global Health), Bruce Neal(UNSW Sydney), Wenyi Niu(Peking University), Jingpu Shi(First Hospital of China Medical University), Darwin R. Labarthe(UK Health Forum), Yi Zhao(Ningxia Medical University), Michael M. Engelgau(World Bank), Stephen MacMahon, Paul Elliott(Ipsen (France)), Lijing L. Yan(Duke University), Bo Zhou, Jianhong Pan(Peking University), Yuhong Zhang(Central Hospital of Zibo), Zhifang Li(Changzhi Medical College), Xian Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yao Chen(Women's Hospital, School of Medicine, Zhejiang University), Ruijuan Zhang(Xi'an Jiaotong University), Yan Yu(Jiangxi University of Traditional Chinese Medicine), Xiangxian Feng(Changzhi Medical College), Jing Zhang(Lanzhou University Second Hospital), Jixiang Ma(Shandong Center for Disease Control and Prevention), Yangfeng Wu(Peking University), Jianxin Zhang(Hebei Provincial Center for Disease Control and Prevention), Jixin Sun(Hebei Provincial Center for Disease Control and Prevention), Zhixin Hao(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongling Chu
Cited by 86
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k